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Abstract    
 
Background The incidence of chronic illnesses is increasing globally. Non-adherence to medications and other medication-
related problems are common among patients receiving long-term medications. Medication use review (MUR) is a service 
provision with an accredited pharmacist undertaking structured, adherence-centered reviews with patients receiving multiple 
medications. MUR services are not yet available in community pharmacies in Qatar. Objective The current study aims to 
evaluate com- munity pharmacists’ knowledge, attitudes, and perception towards establishing MUR as an extended role in 
patient care. Setting Private community pharmacies in Qatar including chains and independent pharmacies. Methodology A 
cross-sectional survey using a self-administered ques- tionnaire was conducted among licensed community phar- macists from 
December 2012 to January 2013. Data analysis was conducted using descriptive and inferential statistics. Main outcome 
measures Knowledge, attitudes, and practices related to MUR concept and services. Results A total of 123 participants 
responded to the survey (response rate 56 %). The mean total knowledge score was 
71.4 ± 14.7 %. An overwhelming proportion of the par- ticipants (97 %) were able to identify the scope of MUR in 
relation to chronic illnesses and at enhancing the quality of pharmaceutical care. Furthermore, 80 % of the respondents were 
able to identify patients of priority for inclusion in an MUR program. However, only 43 % of the participants knew that 
acute medical conditions were not the principal focus of an MUR service, while at least 97 % acknowledged that the provision 
of MUR services is a great opportunity for an extended role of community pharmacists and that MUR makes excellent use 
of the pharmacist’s professional skills in the community. The participants generally reported concerns about time, dedicated 
consultation area, and sup- port staff as significant barriers towards MUR implemen- tation. Conclusion This study suggests 
that community pharmacists in Qatar had sufficient knowledge about the concept of MUR and its scope, but there were 
still important deficiencies that warrant further education. The findings have important implications on policy and practice 
per- taining to the implementation of MUR as an extended role of pharmacists and as part of Qatar’s National Health 
Strategy to move primary health care forward. 
 
 
Impacts of the findings on pharmacy practice 
 
• Further  training  and  education  through  continuing professional development programs are warranted for community 
pharmacists in Qatar before implementing MUR service. 
• In  order  to  implement  MUR  services  in  Qatar,  the service providers should be accredited based on com- petency 
standards and/or credentialing. 
• Future studies should target  pharmacists  working in other primary health care sectors in order to determine their current 
knowledge, attitude, and practices and to determine their educational needs. 
 
 
 
      
 
 
 
 
  
Introduction 
 
The incidence of chronic diseases is increasing globally 
[1].  Non-adherence  to  medications,  polypharmacy  and 
other medication-related problems are common among 
patients receiving long-term medications for chronic ill- 
nesses [2, 3]. Medication use review (MUR) by pharma- 
cists is becoming increasingly important globally as one of 
the strategies to prevent medication misadventures and a 
means to optimize the therapeutic outcomes of long-term 
medication use [4]. MUR is defined as a service provision 
with an accredited pharmacist undertaking structured 
adherence-centered reviews with patients on multiple 
medications (prescribed and non-prescribed), particularly 
those receiving medications for long-term conditions [5] in 
a private consultation area within the pharmacy, where 
patient and pharmacist are able to sit and communicate 
without interference or being overheard by others (phar- 
macy staff inclusive) [6]. Following the MUR, a report is 
provided to the patient and if necessary to the patient’s 
general practitioner [7]. MUR gives an opportunity for 
patients to discuss their medications with a pharmacist, to 
increase understanding of how their medicines should be 
used and why they have been prescribed, as well as solving 
any problems they may be experiencing [8]. By educating 
patients about their medications, the MUR service ulti- 
mately helps patients improve compliance and concor- 
dance, and prevents adverse effects associated with 
polypharmacy. Although the MUR definition used in this 
paper is based on the UK model, MUR would be inter- 
preted differently in different countries and the definition 
used here is just an example of such disparities. 
The community pharmacy MUR service has been widely 
used in many developed countries around the world. MUR, 
as an advanced service, has been available in the United 
Kingdom since April 2005 [6, 8–10]. Similar medication 
reviews form part of community pharmacy services in 
Australia (through the Meds Check program introduced in 
2007) [11, 12], the United States [13, 14] and in New Zea- 
land in 2007 [15]. MUR is not yet established in community 
pharmacies in Qatar and little is known about the existence 
of the service in hospital and primary care settings. 
Pharmacy practice in Qatar is rapidly evolving through 
important transformations and advancements. These can be 
illustrated in the development of cognitive and specialized 
hospital   pharmacy   services,   pharmacy   education,   the 
country’s health plans, and pharmacy leadership [16, 17]. 
Currently, the hospital pharmacy sector in Qatar provides 
clinical pharmacy services that were introduced in some 
government hospitals and facilities in 2006 [17]. Recently 
established government hospitals have been provided with 
automated dispensing devices and computer-aided drug 
distribution systems, sparing pharmacists’ time for direct 
patient care activities and ensuring safe and rational med- 
icines use [17]. However, in the private pharmacy sector, 
the practice is still dominated by dispensing and sales of 
prescription and over-the-counter pharmaceutical products 
[16, 18, 19]. In general, pharmaceutical care, medicines 
management, and other advanced services are not com- 
monplace in community pharmacies in Qatar [16, 18]. 
Therefore, community pharmaceutical services in Qatar are 
predominated by traditional distribution of medicinal pro- 
ducts. Similarly, this trend is reported in the private phar- 
macy sector by most countries in the region, and Qatar is 
no exception [18]. 
The Supreme Council of Health (SCH), which repre- 
sents the highest health authority in Qatar, launched a 
national health agenda known as the National Health 
Strategy (NHS) 2011–2016 in April 2010 [20, 21]. This 
agenda sets out a strategic direction and key initiatives that 
the health sector will undertake from 2011 to 2016, in order 
to achieve the goals of the Qatar National Vision 2030 [22] 
and  National  Development  Strategy  (NDS)  2011–2016 
[23]. The vision has stated clearly that all health services 
will be accessible to the entire population. There are seven 
goals within this strategy; the first is a comprehensive 
world-class healthcare system in which community phar- 
macy strategy is placed. One of the main deliverables and 
outputs in this strategy is an accreditation program for 
pharmacists and pharmacies to provide advanced and 
extended services such as MUR and health promotion. 
To our knowledge, the current study is the first in Qatar 
to investigate community pharmacists’ knowledge, atti- 
tude, and practice pertaining to MUR and in particular the 
potential  impact  of  implementing  MUR  services  as  a 
means of improving the clinical outcomes and cost-effec- 
tiveness of prescribed medicines, and reducing waste. 
 
 
Aim of the study 
 
The purpose of this study was to: (1) assess the availability 
of facilities to support MUR implementation in community 
pharmacies in Qatar; (2) evaluate the pharmacist’s 
knowledge and self-perceived competence in providing the 
MUR service; (3) explore their attitude and perceptions 
towards implementation of MUR; and (4) assess the 
practices  of  the  community  pharmacists  pertaining  to 
MUR. 
  
 
Ethical  approval 
 
Ethical approval for the study was obtained from Institu- 
tional  Review  Board  (IRB)  of  the  Qatar’s  SCH  on  16 
December 2012. The questionnaire was anonymous and no 
names or identity numbers were required. 
 
 
Method 
 
Study design and sample 
 
A descriptive cross-sectional study using a self-adminis- 
tered questionnaire as a research instrument was conducted 
among community pharmacists in Qatar from December 
2012 to January 2013. A sample of 220 pharmacists cur- 
rently practicing in different cities and pharmacies was 
randomly selected to participate in the study. The sample 
size was estimated using the Raosoft®   online calculator 
[24]. There were approximately 500 community pharma- 
cists practicing in Qatar. In order to achieve a confidence 
level  of  95 %  and  a  5 %  margin  of  error, a  minimum 
sample size of 180 was required. However, based on our 
previous  experience  with  research  culture  and  response 
rates in this country, we accounted for a non-response rate 
of 20 %. Therefore, a random sample of 220 community 
pharmacists was selected to participate in the study. 
 
Study setting 
 
The study involved pharmacists practicing in the private 
community pharmacy setting. Pharmacies in which 
respondents were employed can be categorized as either 
large multiples (pharmacy chain with greater than 10 out- 
lets), medium multiples (pharmacy chain with 4–9 phar- 
macies), small multiples (pharmacy chain with 2–3 
pharmacies), or single independent pharmacies. 
 
Eligibility criteria 
 
Inclusion criteria for potential respondents included: (1) 
being licensed as a practicing pharmacist in Qatar; (2) 
currently working as a community pharmacist and; (3) being 
working in a community pharmacy in Qatar for at least 12 
months. 
 
Survey instrument development and implementation 
 
The questionnaire was developed with reference to the lit- 
erature pertaining to MUR activities and MUR competen- 
cies [7, 9–12, 15], and after consultation with researchers 
and licensed community pharmacists. To improve face 
validity, the questionnaire was piloted on six community 
pharmacists (those who work in different community 
pharmacies with different general experiences and also with 
different nationalities and years of experiences in Qatar— 
who were eventually not included as study participants). 
Questions were designed to be comprehensive, and included 
four sections: demographics, knowledge, attitudes and 
practice, which were applicable to all respondents. The 
knowledge section consisted of 20 knowledge statements 
with true or false or unsure response options covering 4 
areas: (1) MUR definition and conditions of implementa- 
tion; (2) aims of the MUR service; (3) identification of 
patients for potential inclusion in an MUR program; and (4) 
important service elements in conducting an MUR. One 
point was awarded for each correct response and zero points 
for each incorrect or unsure response. The maximum pos- 
sible score was 20 points (equivalent to 100 %). The attitude 
section of the survey tool consisted of 15 five-point Likert 
scaled   attitudinal   questions  (1 = strongly  disagree  to 
5 = strongly agree). Attitudinal statements composed of 
three main areas: views about pharmacists’ extended role of 
MUR service, effectiveness of the service, and implemen- 
tation barriers. While in the last section, the questionnaire 
included 15 Likert scaled practice and availability of facil- 
ities  statements  (1 = strongly  disagree  to  5 = strongly 
agree). These statements portrayed the willingness to pro- 
vide MUR services within daily practice activities, time 
allocation to provide these services, availability of infor- 
mation technology (IT), administrative support, and devel- 
opment of structured training programs before commencing 
MUR services including a responsible body for accredita- 
tion of MUR services provision. 
The survey was launched by distributing question- 
naires through personal visits to pharmacies in Decem- 
ber 2012, along with an explanatory statement to inform 
each participant about the purpose and objectives of the 
study, as well as the confidentiality of the survey results 
and that no efforts would be made to track individual 
responses. 
 
Statistical analysis 
 
The collected data from returned questionnaires were 
entered into IBM Statistical Package for Social Science 
(IBM SPSS®  Statistics) version 20 for analysis. Both 
descriptive and inferential statistics were used for the 
analysis. Community pharmacists’ demographic informa- 
tion and professional characteristics were calculated as 
frequencies and percentages (i.e. proportions) since they 
were all categorical variables. Proportions were also used 
to portray the respondents’ knowledge, attitudes and practice 
on MUR. Respondents’ total knowledge score was further 
calculated as mean ± SD. Independent t test and One-way 
ANOVA test were used to determine the effect of 
  
 
Table 1  Demographic and professional characteristics of community 
pharmacists in Qatar (n = 116) 
Table 1 continued 
   Characteristics Proportion, n (%) 
Characteristics Proportion, n (%) 
 
Gender 
Male                                                                             74 (63.8) 
Female                                                                         42 (36.2) 
Nationality 
Indian 56 (48.3) 
Egyptian 31 (26.7) 
Filipino 18 (15.5) 
Syrian  3 (2.6) 
Palestinian  2 (1.7) 
Others  6 (5.2) 
Age category (years) 
25–34 70 (60.3) 
35–44 38 (32.8) 
45–54 8 (6.9) 
Highest pharmacy degree obtained 
BSc 112 (96.6) 
MSc  4 (3.4) 
Country of highest degree 
India 58 (50) 
Egypt 31 (26.7) 
Philippines 18 (15.5) 
Jordan  2 (1.7) 
Pakistan  2 (1.7) 
Others  5 (4.4) 
Years of experience* 
>2 4 (3.5) 
2–5 26 (23.0) 
6–10 36 (31.9) 
11–15 32 (28.3) 
16–20 12 (10.6) 
>21  3 (2.7) 
Years of community practice in Qatar 
<2 33 (28.4) 
2–5 40 (34.5) 
6–10 26 (22.4) 
11–15 14 (12.1) 
16–20 3 (2.6) 
Weekly working hours 
<10 7 (6.0) 
10–19 1 (0.9) 
20–29 3 (2.6) 
30–39  5 (4.3) 
C40 100 (86.2) 
Attitude towards practice change* 
Willing to take risks                                                   38 (35.2) 
Serve as a role model                                                 44 (40.7) 
Deliberate before adopting new changes                   20 (18.5) 
Tend to change once most peers have done so           4 (3.7) 
Resist new ways of working                                        2 (1.9) 
 
* Some missing data 
 
 
sociodemographic and professional characteristics on 
pharmacists’ MUR knowledge. The level of significance 
was set a priori at p < 0.05. 
 
 
Results 
 
Demographic and professional characteristics 
of the respondents 
 
One hundred twenty-three community pharmacists from 
different  pharmacy  ownership  throughout  the  State  of 
Qatar completed the survey (response rate was 56 %). Of the 
123 returned surveys, only 116 were useable; surveys in 
which the respondents skipped 5 or more questions were 
excluded to preserve the data quality. 
The majority of the respondents (74/116; 63.8 %) were 
male (Table 1). Half (58/116) of the respondents obtained 
their highest pharmacy degree from India, followed by Egypt 
(31/116; 26.7 %), Philippines (18/116; 15.5 %), and the rest 
of the respondents were from other countries. The vast 
majority of the participants (112/116; 96.6 %) pos- sessed 
BSc degree as the highest pharmacy degree. The majority 
(83.2 %) of the pharmacists who responded to the survey 
had general pharmacy experience between 2 and 
15 years. Other details on the sociodemographic and pro- 
fessional characteristics of the respondents are provided in 
Table 1. 
 
Community pharmacists’ knowledge 
towards medication use review 
 
Table 2 presents the respondents’ knowledge on different 
aspects of MUR. Approximately, 93.1 % (108/116) of the 
respondents knew the general definition of MUR. In 
addition to that, the majority of the respondents (96.6 %; 
112/116) were able to identify the scope of MUR services 
pertaining to chronic diseases such as diabetes, asthma and 
hypertension. However, only 43.4 % (49/113) knew that 
MUR  services  are  not  usually  provided  for  acute  and 
critical conditions such as acute myocardial infarction and 
acute decompensated heart failure. 
Approximately  96.6 %  (112/116)  of  the  community 
pharmacists surveyed had correctly answered the question 
that ‘‘MUR service is aimed at enhancing the quality use of 
  
 
 
Table 2  Knowledge of medication use review among community pharmacists in Qatar (n = 116) 
Knowledge items N (%) 
True False Not sure 
 
General MUR definition and condition of implementation 
1 MUR is a service that involves an accredited pharmacist undertaking structured 
concordance centered reviews with patients on multiple medicines, particularly 
those receiving medicines for long-term conditions 
 
108 (93.1) 2 (1.7) 6 (5.2) 
2 MUR is more important for chronic diseases such as diabetes, asthma, and hypertension 112 (96.6) 3 (2.6) 1 (0.9) 
3 MUR services are provided for in-patients who present with acute or critical 
condition e.g. acute myocardial infarction (MI)* 
Aims of MUR services 
49 (43.4) 36 (31.9) 28 (24.8) 
4 MUR is aimed at enhancing the quality use of medicines and reducing the number 
of adverse drug events 
112 (96.6) 2 (1.7) 2 (1.7) 
5 MUR is aimed to identify problems that the patients may be experiencing with their 
disease states 
91 (78.4) 13 (11.2) 12 (10.3) 
6 MUR is aimed to help patients become experts on medications* 74 (64.3) 19 (16.5) 22 (19.1) 
7 MUR is aimed to help in improving the effective use of medicines by patients including 103 (88.8) 3 (2.6) 10 (8.6) 
learning about how the medicines affect their diseases 
Identified patients’ priority for potential inclusion in an MUR program 
8 Taking more than five regular medicines, 12 doses of medicine per day or being 
treated for three medical conditions 
100 (86.2) 6 (5.2) 10 (8.6) 
9 Discharged from hospital in last 4 weeks* 63 (54.8) 21 (18.3) 31 (27.0) 
10 Medication regimen changed in last 3 months* 89 (77.4) 8 (7.0) 18 (15.7) 
11 Taking a medicine with narrow therapeutic index or requiring therapeutic drug 
monitoring 
96 (82.8) 8 (6.9) 12 (10.3) 
12 Symptoms suggestive of an adverse drug reaction (ADR) symptoms* 99 (86.1) 6 (5.2) 10 (8.7) 
13 Suspected non-compliance to multiple medications* 91 (79.8) 9 (7.9) 14 (12.3) 
14 Problems managing medication-related to therapeutic devices such as asthma 
inhalers and insulin pen 
94 (81.0) 11 (9.5) 11 (9.5) 
15 Dexterity problems e.g. impaired sight* 58 (50.4) 23 (20.0) 34 (29.6) 
16 Risk due to language/literacy difficulties 66 (56.9) 23 (19.8) 27 (23.3) 
Important service elements in conducting MUR 
17 Gathering relevant information from the patient or the patient’s caregiver 106 (91.4) 4 (3.4) 6 (5.2) 
18 Reviewing and discussing the patient’s use of all medicines 107 (92.2) 2 (1.7) 7 (6.0) 
and medication/monitoring devices 
19 Developing action plan including GP follow up* 84 (73.0) 7 (6.1) 24 (20.9) 
20 Arranging agreed follow-up actions 90 (77.6) 8 (6.9) 18 (15.5) 
 
* Some missing data 
 
medicines and reducing the number of adverse drug events 
experienced by the patients’’. Similarly, 64.3 % (74/115) of 
the participants incorrectly assumed that MUR is aimed to 
help patients become medication therapy experts. 
The  majority  of  the  respondents  (86.2 %;  100/116) 
knew that MUR should be implemented for patients who 
are ‘‘taking more than five regular medicines, 12 doses of 
medicines per day or being treated for three medical con- 
ditions’’. Similarly, a large proportion of the respondents 
correctly identified the following eligibility criteria for 
MUR program: problems managing the usage of thera- 
peutic devices such as asthma inhalers and insulin pens 
(81 %; 94/116), taking medicines with narrow therapeutic 
indices  (82.8 %;  96/116),  and  symptoms  suggestive  of 
  
 
ADRs (86.1 %; 99/115). Despite the large proportion of the 
surveyed pharmacists’ knowledge regarding the potential 
inclusion criteria to MUR service, a non-negligible per- 
centage (27 %) were unsure whether these services could 
be implemented for those who were discharged from hos- 
pital in the last 4 weeks. 
At least three-quarters of the respondents were aware 
that elements such as gathering relevant information about 
patient history, reviewing the patient use of medicines and 
monitoring devices, developing a written action plan and 
follow up actions, are important service elements in con- 
ducting a MUR (Table 2). 
Overall, the highest total knowledge score among the 
community pharmacists surveyed was found to be 95 % 
  
 
Table 3  The influence of Qatar community pharmacists’ character- 
istics on their knowledge about medication use review (n = 116) 
where pharmacists who aspired to serve as role models had 
the highest level of knowledge, while those who described 
Characteristics Mean 
knowledge 
score (SD) 
p value§ themselves as resistant to new ways of working had the 
least knowledge (76.1 vs. 55.0, respectively; p = 0.032). 
 
Overall mean knowledge score (range)                                                    – 
71.4 ± 14.7 % (80 %) 
Gender  0.531* (NS) 
Male 72.0 (13.8) 
Female                                                                           70.2 (16.3) 
Age category (years)                                                                                 0.777 (NS) 
25–34                                                                            70.6 (12.4) 
35–44                                                                            72.8 (17.8) 
45–54                                                                            71.3 (18.7) 
Highest pharmacy degree obtained  0.380 (NS) 
BSc 71.6 (14.9) 
MSc                                                                               65.0 (7.1) 
Years of experience                                                                                   0.133 (NS) 
\2                                                                                  66.3 (8.5) 
2–5                                                                                67.7 (13.7) 
6–10                                                                              69.7 (15.1) 
11–15                                                                            75.9 (11.6) 
16–20                                                                            67.5 (22.1) 
[21                                                                                83.3 (2.9) 
Years of community practice in Qatar                                                      0.135 (NS) 
\2                                                                                  69.4 (11.0) 
2–5                                                                                68.4 (17.4) 
6–10                                                                              77.5 (12.9) 
11–15                                                                            73.2 (14.6) 
16–20                                                                            71.7 (18.9) 
Weekly working hours                                                                               0.868 (NS) 
\10                                                                                69.3 (18.4) 
10–19                                                                            60.0 (–) 
20–29                                                                            76.7 (7.6) 
30–39                                                                            74.0 (6.5) 
C40                                                                                71.4 (15.0) 
Attitude towards practice change  0.032 (S) 
Willing to take risks 70.0 (14.1) 
Serve as a role model                                                   76.1 (10.4) 
Deliberate before adopting new changes                     65.8 (20.9) 
Tend to change once most peers have done so           67.5 (17.1) 
Resist new ways of working                                        55.0 (21.2) 
§   p values were calculated using One-way ANOVA test 
* p values was calculated using independent t test 
S significant, NS non-significant 
 
 
 
and the minimum was 15 %. The mean total knowledge 
score (±SD)  was 71.4 ± 14.7 % (Table 3). Further anal- 
yses were conducted to determine the influence of the 
pharmacists’ demographic and professional characteristics 
on  their  knowledge  of  MUR  (Table 3).  Gender,  age, 
highest pharmacy  degree  obtained,  years of  experience, 
and weekly working hours, all had no significant effect on 
the  knowledge  (p [ 0.05).  However,  attitude  towards 
practice change had significant effect on the knowledge; 
  
 
Community pharmacists’ attitudes towards medication 
use review 
 
The respondents generally exhibited positive attitudes 
toward  MUR  service  provision  (Table 4).  Information 
collected regarding the attitudinal statements was in almost 
universal acknowledgement that: MUR service is a great 
opportunity for an extended role of community pharmacists 
(96.5 %; 112/116); MUR makes an excellent use of the 
pharmacist’s professional skills in the community (95.7 %; 
110/115); through the MUR service, pharmacists’ under- 
standing of their patients views about medicines will be 
enhanced   (91.2 %;   104/114).   The   majority   (87.9 %; 
102/116) of the respondents disagreed with the statement 
that MUR service was a waste of the community phar- 
macist’s time. In addition, this was supported also by a 
high expression of disagreement (83.6 %; 97/116) with the 
statement that community pharmacists would not like to 
see more advanced services introduced in the future. 
Furthermore, there was a high expression of disagree- 
ment with the suggestion that MURs would not improve 
patient compliance (81 %; 94/116) or cost-effectiveness of 
prescribed medication  (66.1 %;  76/115). Less  than  half 
(41.7 %; 48/115) of the surveyed pharmacists believed that a 
lack of access to medical records reduces the benefits of 
MUR services, and a sizeable proportion (59.5 %; 69/116) 
believed that patients would want a community pharmacist 
to  review  their  medications.  More  than  half  (57.7 %; 
67/116) of the respondents felt that there was enough time 
to carry out MUR services. However, there was no con- 
sensus as to the availability of adequate supporting staff to 
provide MUR services. Three-quarters of the pharmacists 
agreed to conduct MUR services if they had a suitable 
consultation area. In contrast, only 40.5 % (47/116) of the 
respondents were willing to provide more MURs if pro- 
vided with a reasonable financial incentive. 
 
Practice and availability of facilities related 
to medication use review 
 
Most (87 %; 100/115) of the surveyed pharmacists were 
willing to provide MUR services in spite of their engage- 
ment   with   other   daily   practice   activities   (Table 5). 
Regarding availability of facilities to support MUR ser- 
vices establishment and continuous provision in commu- 
nity  pharmacies,  it  was  found  that  less  than  a  quarter 
(23.3 %; 27/116) of the surveyed pharmacists agreed that 
there was sufficient IT support. 
  
 
 
Table 4  Attitude towards medication use review and its implementation among Qatar community pharmacists (n = 116) 
 
Attitudinal items N (%) 
 
Strongly 
agree 
 
Agree Neutral Disagree Strongly 
disagree 
 
Attitudes towards MUR as an extended role 
1 The MUR service is a great opportunity for an extended role for community 
pharmacists 
2 MUR makes excellent use of the pharmacist’s professional skills in the 
community* 
3 Pharmacists understanding of their patients views about medicines will be 
enhanced by the MURs* 
 
65 (56.0)   47 (40.5) 4 (3.4) 0 (0) 0 (0) 
 
70 (60.9)   40 (34.8) 5 (4.3) 0 (0) 0 (0) 
 
51 (44.7)   53 (46.5) 7 (6.1) 2 (1.8) 1 (0.9) 
4 The MUR service is a waste of the pharmacist’s time 2 (1.7) 4 (3.4) 8 (6.9) 52 (44.8)   50 (43.1) 
5 I would not like to see more of these new services in the future 6 (5.2) 7 (6) 6 (5.2) 49 (42.2)   48 (41.4) 
Attitudes towards the perceived effectiveness of MUR to patients 
6 The MUR service will improve poor or ineffective use of the patient’s medicine    49 (42.2)   51 (44.0) 6 (5.2) 5 (4.3) 5 (4.3) 
7 The MUR service will not improve patient compliance to drug therapy 2 (1.7) 5 (4.3) 15 (12.9)   63 (54.3)   31 (26.7) 
8 The MUR service will not improve the cost-effectiveness of prescribed 
medication* 
9 Without access to medical notes, patients will not see the full benefit from the 
review* 
10   In my opinion, patients simply may not want the pharmacist to review their 
medications 
Attitudes towards perceived barriers 
1 (0.9) 8 (7.0) 30 (26.1)   49 (42.6)   27 (23.5) 
 
5 (4.3) 43 (37.4)   34 (29.6)   26 (22.6) 7 (6.1) 
 
3 (2.6) 14 (12.1)   30 (25.9)   50 (43.1)   19 (16.4) 
11   I simply do not have enough time to carry out MUR 4 (3.4) 18 (15.5)   27 (23.3)   47 (40.5)   20 (17.2) 
12   I have enough supporting staff to enable me to conduct MURs to my satisfaction    11 (9.5) 30 (25.9)   41 (35.3)   30 (25.9) 4 (3.4) 
13   I would conduct more MURs if I had a reasonable financial incentive 19 (16.4)   28 (24.1)   42 (36.2)   21 (18.1) 6 (5.2) 
14   I could conduct many MURs if I had a suitable consultation area 27 (23.3)   61 (52.6)   23 (19.8) 5 (4.3) 0 (0) 
15   I think GPs see MURs as a valuable contribution to patient care 31 (26.7)   49 (42.2)   28 (24.1) 4 (3.4) 4 (3.4) 
 
* Some missing data 
 
A large proportion of the participants (94.8 %; 109/115) 
agreed that training programs should be conducted under 
the control of the SCH for the purpose of education and 
orientation of community pharmacists before implement- 
ing MUR services in Qatar. Moreover, there was universal 
agreement (95.6 %; 111/116) that the training programs 
should involve the academia (universities) along with SCH. 
Remuneration is a major issue impinging on community 
pharmacist’s participation in MUR services. As a result, 
three-quarters of the respondents indicated that the gov- 
ernment should reimburse the MUR service provider, while 
only  23.3 %  (27/116)  believe  that  patients  should  be 
charged for MUR services. 
 
 
Discussion 
 
Although MUR as an advanced pharmacy service, is yet to 
be implemented in community pharmacies in Qatar as an 
additional service alongside the traditional dispensing ser- 
vices, community pharmacists have demonstrated willing- 
ness to be involved in such a service for the purpose of 
  
improving patient care. There is a great incentive for the 
implementation of MUR in Qatar, as considerable efforts to 
raise the pharmacist’s public image and professional role 
are underway. This effort should demonstrate the potential 
benefits of extending pharmacists’ contributions to phar- 
maceutical care beyond accurate dispensing and the pro- 
vision of basic counseling. 
The pharmacist guidelines for the provision of Home 
Medication Review (HMR) services, published by Phar- 
maceutical Society of Australia in October 2011 [25], 
identified patients who could benefit from HMR including 
those who are at risk of medications misadventure due to 
multiple conditions, co-morbidities, discharge from a hos- 
pital in the past 4 weeks, and those patients who self-manage 
their own medications and are at risk due to literacy or 
language difficulties and those with dexterity problems (e.g. 
impaired vision and cognitive deteriorations). This survey 
has shown that non-negligible proportions (23–30 %) of the 
respondents were unsure as to whether these services could 
be implemented for those patients who were discharged from 
hospital within the past 4 weeks, and whether dexterity 
problems and languages/literacy difficulties should also be 
  
 
Table 5  Future practice of medication use review and availability of facilities in Qatar community pharmacies 
 
Survey items N (%) 
 
Strongly 
agree 
 
Agree Neutral Disagree Strongly 
disagree 
 
1 I have the willingness to provide MUR services within my daily practice 
activities* 
2 I have sufficient time within my daily work to provide MUR services for more 
than 1 day a week 
3 I have sufficient IT support to provide MUR services in my community 
pharmacy 
34 (29.6)   66 (57.4)   12 (10.4) 3 (2.6) 0 (0) 
 
13 (11.2)   43 (37.1)   35 (30.2)   23 (19.8) 2 (1.7) 
 
7 (6.0) 20 (17.2)   41 (35.3)   43 (37.1) 5 (4.3) 
4 I have sufficient administrative support to provide MUR services 5 (4.3) 35 (30.2)   43 (37.1)   30 (25.9 3 (2.6) 
5 Training programs to be done by SCH* 66 (57.4)   43 (37.4) 6 (5.2) 0 (0) 0 (0) 
6 Involvement of Universities along with SCH for orientation and education of 
community pharmacist before implementing MUR services 
62 (53.4)   49 (42.2) 5 (4.3) 0 (0) 0 (0) 
7 I already have sufficient training to provide MUR services 6 (5.2) 13 (11.2)   43 (37.1)   50 (43.1) 4 (3.4) 
8 I have enough experience of being involved in MUR 12 (10.3)   31 (26.7)   36 (31.0)   36 (31.0) 1 (0.9) 
9 Already providing MUR services in my community pharmacy* 8 (7.0) 27 (23.5)   39 (33.9)   37 (32.2) 4 (3.5) 
10   Accreditation of community pharmacy and pharmacists* 40 (35.1)   53 (46.5)   18 (15.8) 1 (0.9) 2 (1.8) 
11   Community pharmacist’s accreditation should be obtained from SCH or an 
academic institution 
43 (37.1)   55 (47.4)   14 (12.1) 3 (2.6) 1 (0.9) 
12   Government should reimburse the MUR service provider 34 (29.3)   53 (45.7)   26 (22.4) 3 (2.6) 0 (0) 
13   Insurance company should reimburse the MUR service provider 27 (23.3)   46 (39.7)   35 (30.2) 7 (6.0) 1 (0.9) 
14   Patient should also be charged for MUR services 5 (4.3) 22 (19.0)   31 (26.7)   43 (37.1)   15 (12.9) 
15   Availability of a screened area in the community pharmacy for MUR services 9 (7.8) 20 (17.2)   22 (19.0)   46 (39.7)   19 (16.4) 
 
* Some missing data 
 
 
 
 
considered. These points of uncertainty call for stipulation of 
mandatory education and training programs before com- 
mencing MUR services in Qatar. 
The  respondents acknowledged  that  the  provision  of 
MUR services is a great opportunity for an extended role of 
community pharmacist and that MUR makes an excellent 
use of the pharmacist’s professional skills in the commu- 
nity. This is in line with what has been reported among 
community pharmacists in the UK on moving their pro- 
fessional skills towards best practices and new extended 
roles [7]. Furthermore, GP’s acknowledgement of phar- 
macists’ skill and knowledge, with regard to medicines and 
the potential benefit of extending new services were found 
by other studies [26, 27]. 
Since April 2005, at the time of implementation of MUR 
services in community pharmacies in the UK [9] and to date, 
there were many successful attempts around the globe to 
implement these services, such as in New Zealand [15], for 
the purpose of improving patients’ use of medicine, patient 
compliance and cost-effectiveness of prescribed 
medications [28, 29]. A significant number of surveyed 
pharmacists in this study were found to agree with these 
benefits. However, lack of access to medical records 
reduced the benefits of MUR services. 
  
This study highlights some of the barriers perceived by the 
pharmacists affecting their involvement in the future provi- 
sion of MUR services in Qatar. The majority were willing to 
conduct these services once a suitable consultation area was 
available, and interestingly they were willing to provide the 
service without consideration of the amount of incentive 
expected through remuneration. All the previous attitudinal 
points need to be investigated or further studied after imple- 
mentation of the MUR program, to compare the current the- 
oretical data with a practical dataset. On the other hand, once 
these highlighted barriers are addressed, the workload of the 
community pharmacists may increase, and this may present as 
a barrier in the future [30]. Many of the surveyed pharmacists 
thought that GPs would consider MURs as a valuable con- 
tribution to patient care in Qatar. In agreement with the 
findings from other studies, GPs expressed a positive attitude 
towards pharmacists expanding their roles of service if a good 
working relationship was established [27]. In addition, closer 
collaboration between GPs and pharmacists could potentially 
improve patients’ use of medicines [31]. However, some 
previous reports have highlighted some isolated incidences of 
reluctance or slow GP referral [15]. 
This survey revealed that less than half of the surveyed 
pharmacists agreed that there was sufficient IT support and 
  
 
administrative support for these services. These findings 
are related to the availability of facilities to support MUR 
establishment and continuous provision in community 
pharmacies. Hence great efforts need to be made to ensure 
that the support and readiness for MUR provision are in 
place  before  implementation.  This  is  supported  by  the 
Qatar NHS goals, to improve healthcare in Qatar to the 
level of comprehensive world-class healthcare system, 
whose services are accessible to the whole population. This 
is in line with achieving the goal of the Qatar National 
Vision 2030 [22] and the NDS 2011–16 [23, 32]. 
A large proportion of the participants indicated that 
training and education programs should be conducted for 
community pharmacists under the control of SCH, with the 
involvement of academia, before implementing MUR ser- 
vices. This would be a prerequisite for the accreditation of 
pharmacists who are willing to participate in an MUR 
services program, as per the requirements of other coun- 
tries offering MUR in the community pharmacy setting [7, 
9, 11, 15]. 
This study has some important limitations that are 
inherent to most survey-type studies. First, the response rate, 
although relatively high compared to similar studies 
conducted in Qatar, is an issue of concern. Therefore, the 
results may not be generalized and representative of all 
community pharmacists in Qatar, but did provide an indi- 
cation of the attitude of a reasonable number of community 
pharmacists in the country. Second, the questionnaire was 
distributed using hardcopy, subjecting the responses to bias 
due to possibility of communication among the respon- 
dents. Third, social desirability bias might have influenced 
how the pharmacists responded to the attitudinal items. 
Lastly, it is worthwhile to stress that the MUR definition 
used  here  originates  from  the  UK  and  the  survey  tool 
looked into the implementation of some specific models of 
MUR. Future studies should investigate the perceptions of 
the pharmacists towards a model that is customized to Qatar. 
 
 
Conclusions 
 
Pharmacists in Qatar have sufficient knowledge regarding 
the concept of MUR and its scope, despite some areas of 
deficiencies and misconception about the practice. Phar- 
macists need to be educated and trained about the potential 
benefits of MUR in improving the overall outcome of 
healthcare. This calls for a systematic and structured training 
program encompassing the core elements of MUR services 
and processes prior to implementation. This study has 
documented an apparent lack of availability of facilities and 
environment for the provision of MUR, such as dedi- cated  
consultation  area  and  IT  support  system.  This 
warrants advocacy by pharmacy owners and regulators for 
improvement of facilities. 
The current findings have important implications on the 
implementation of MUR services as an extended role for 
pharmacists and as part of Qatar’s NHS 2011–2016 agenda 
to move primary health care forward. As per best practices 
and international standards, mandatory accreditation of any 
pharmacist who plans to provide such extended services is 
warranted. 
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